Join our mailing list to receive the latest updates and alerts Flag Subscribe

In addition to the COVID-19 Prioritized Trademark Examination Program initiated by the United States Patent and Trademark Office (USPTO) in June of 2020, the USPTO is now launching a Pilot Prioritized Review Program for Appeals Related to COVID-19 where the Trademark Trial and Appeal Board (TTAB) will expedite the review and issuance of ex parte appeal decisions for applications examined under the COVID-19 Prioritized Trademark Examination Program.

The USPTO will also launch a Conference Pilot Program for Oppositions Against Applications Related to COVID-19 where a TTAB attorney or judge may participate in the parties’ mandatory settlement and discovery planning conference, if the involved application was examined under the COVID-19 Prioritized Trademark Examination Program.

These changes are welcomed given the need to quickly get medical products and services to market in response to COVID-19.

For more information, contact a member of the Advertising, Marketing & Trademark Group.


Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.